|

Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

RECRUITINGN/ASponsored by Kenyatta National Hospital
Actively Recruiting
PhaseN/A
SponsorKenyatta National Hospital
Started2025-12-01
Est. completion2026-12
Eligibility
Age25 Years – 49 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07050745

Summary

This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).

Eligibility

Age: 25 Years – 49 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

\- Women ages 25-49 years

Exclusion Criteria:

* Pregnant women
* Women ≤6 weeks postpartum
* Women already confirmed to have cervical cancer

Conditions4

CancerCervical CancerCervical Cancer ScreeningHPV DNA

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.